Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01267227 · ClinicalTrials.gov registry record · Phase 2
Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress
A Phase 2 study of Blood Pressure and Oxidative Stress, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT01267227: Completed Phase 2 study of Blood Pressure and Oxidative Stress, sponsored by University of Mississippi Medical Center.
NCT01267227 is a Phase 2 study of Blood Pressure and Oxidative Stress that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 80 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01267227, a Phase 2 study of Blood Pressure and Oxidative Stress, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Pterostilbene is one of several stilbenes found in certain berries, particularly blueberries, that have demonstrated pre-clinical benefit to cholesterol, blood pressure, and oxidative stress. The purpose of this study is to evaluate whether pterostilbene will help control cholesterol and blood pressure, as well as improve markers for oxidative stress in patients with dyslipidemia meeting inclusion criteria. The investigators also want to look at the safety of pterostilbene in these patients.
Primary Outcome
Increase in low density lipoprotein (LDL)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pterostilbene 50 mg twice daily
- DRUG Grape Extract
- DRUG Pterostilbene 125 mg twice daily
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-02 |
| Phase | Phase 2 |
What the finished NCT01267227 record still lists
NCT01267227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (72% lower).
The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT01267227 reports a single indexed study location in Mississippi.
Frequently Asked Questions
What is clinical trial NCT01267227 about?
NCT01267227 is a clinical study titled "Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress". Pterostilbene is one of several stilbenes found in certain berries, particularly blueberries, that have demonstrated pre-clinical benefit to cholesterol, blood pressure, and oxidative stress. The purpose of this study is to evaluate whether pterostilbene will help control cholesterol and blood press...
What is the current status of trial NCT01267227?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2010-12. Estimated completion is 2012-02.
What conditions does trial NCT01267227 study?
This clinical trial studies the following conditions: Blood Pressure, Oxidative Stress, Hyperlipidemia.
What interventions are being tested in trial NCT01267227?
The interventions under investigation include: Placebo (DRUG), Pterostilbene 50 mg twice daily (DRUG), Grape Extract (DRUG), Pterostilbene 125 mg twice daily (DRUG).
Who is sponsoring clinical trial NCT01267227?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01267227 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01267227's enrollment target sits among peer trials
80 46th of 101 higher than 55 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
RECRUITING · Phase 2
-
Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
COMPLETED · Phase 2
-
Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress
COMPLETED · Phase 2
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia